Pharma

Your Article Summary

See Latest Articles

CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam
Cryolife, 10/28/09

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced that the U.S. Food and Drug Administration has granted approval for the company's Investigational Device Exemption to conduct a human clinical trial for its BioFoam Surgical Matrix protein hydrogel technology. BioFoam will be used to help seal liver parenchymal tissue when cessation of bleeding by ligature or other conventional methods is ineffective or impractical.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

See All of Drug/Product Approvals